Quantcast
Home > Quotes > NBSE

NeuBase Therapeutics, Inc. Common Stock (NBSE) Quote & Summary Data

NBSE 
$4.75
*  
0.1949
3.94%
Get NBSE Alerts
*Delayed - data as of Aug. 16, 2019  -  Find a broker to begin trading NBSE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 5.0753 / $ 4.65
Share Volume
54,287
50 Day Avg. Daily Volume
190,096
Previous Close
$ 4.9449
52 Week High / Low
$ 6.28 / $ 1.582
Market Cap
81,047,735
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
54,287
50 Day Avg. Daily Volume:
190,096

Trading Range

The current last sale of $4.75 is 200.25% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.0753 $ 6.28
 Low: $ 4.65 $ 1.582

Company Description (as filed with the SEC)

Ohr Pharmaceutical, Inc. ("we," "us," "our," "Ohr," or the "Company") is a pharmaceutical company which has been focused on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Recent Developments On January 2, 2019, the Company, Ohr Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Ohr ("Merger Sub"), and NeuBase Therapeutics, Inc., a Delaware corporation ("NeuBase"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into NeuBase, with NeuBase becoming a wholly-owned subsidiary of the Company and the surviving corporation of the merger (the "Merger").  ... More ...  

Nasdaq Official Price

Open Price:
$ 4.94
Open Date:
Aug. 16, 2019
Close Price:
$ 4.75
Close Date:
Aug. 16, 2019


Research Brokers before you trade

Want to trade FX?

Analyst Info